Cited by 176Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.

Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers

Open access

Christiaans, Imke, van Engelen, Klaartje, van Langen, Irene M., Birnie, Erwin, Bonsel, Gouke J., Elliott, Perry M., Wilde, Arthur A.M.·2010·EP Europace

DOI 10.1093/europace/eup431

Open this paper in CoChat — free account

Abstract

We performed a systematic literature review of recommended 'major' and 'possible' clinical risk markers for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM). We searched the Medline, Embase and Cochrane databases for articles published between 1971 and 2007. We included English language reports on HCM patients containing follow-up data on the endpoint (sudden) cardiac death using survival analysis. Analysis was undertaken using the quality of reporting of meta-analyses (QUORUM) statement checklist. The quality was checked using a quality assessment form from the Cochrane Collaboration. Thirty studies met inclusion criteria and passed quality assessment. The use of the six major risk factors (previous cardiac arrest or sustained ventricular tachycardia, non-sustained ventricular tachycardia, extreme left ventricular hypertrophy, unexplained syncope, abnormal blood pressure response, and family history of sudden death) in risk stratification for SCD as recommended by international guidelines was supported by the literature. In addition, left ventricular outflow tract obstruction seems associated with a higher risk of SCD. Our systematic review provides sound evidence for the use of the six major risk factors for SCD in the risk stratification of HCM patients. Left ventricular outflow tract obstruction could be included in the overall risk profile of patients with a marked left ventricular outflow gradient under basal conditions.

Integrity signals

Registry

Crossref · 10.1093/europace/eup431

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Contemporary Definitions and Classification of the Cardiomyopathies
Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C. N., Corrado, D., Arnett, D. K., Moss, A. J., Seidman, C. E., & Young, J. B. (2006) · Circulation · doi:10.1161/circulationaha.106.174287 · Cited by 3,424
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
Maron, B. J., McKenna, W. J., Danielson, G. K., KAPPENBERGER, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,572
Hypertrophic Cardiomyopathy
Richard, P., Charron, P., Carrier, L., Ledeuil, C., Cheav, T., Pichereau, C., Benaiche, A., Isnard, R., Dubourg, O., Burban, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000066323.15244.54 · Cited by 1,276
Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy
Spirito, P., Bellone, P., Harris, K. M., Bernabò, P., Bruzzi, P., & Maron, B. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422403 · Cited by 1,142
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
Elliot, P. M., Poloniecki, J. D., Dickie, S., Sharma, S., Monserrat, L., Varnava, A. M., Mahon, N., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 976
Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., et al. (2007) · JAMA · doi:10.1001/jama.298.4.405 · Cited by 802
Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy
Cecchi, F., Olivotto, I., Gistri, R., Lorenzoni, R., Chiriatti, G., & Camici, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025050 · Cited by 776
Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic Cardiomyopathy
Niimura, H., Bachinski, L. L., Sangwatanaroj, S., Watkins, H. C., Chudley, A. E., McKenna, W. J., Kristinsson, A., Roberts, R., Sole, M. J., Maron, B. J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381802 · Cited by 757
Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy
Olivotto, I., Cecchi, F., Casey, S. A., Dolara, A., Traverse, J. H., & Maron, B. J. (2001) · Circulation · doi:10.1161/hc4601.097997 · Cited by 745
Characteristics and Prognostic Implications of Myosin Missense Mutations in Familial Hypertrophic Cardiomyopathy
Watkins, H. C., Rosenzweig, A., Hwang, D., Levi, T., McKenna, W. J., Seidman, C. E., & Seidman, J. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261703 · Cited by 742
Epidemiology of hypertrophic cardiomyopathy-Related death: Revisited in a large non-referral-based patient population
Maron, B. J., Olivotto, I., Spirito, P., Casey, S. A., Bellone, P., Gohman, T. E., Graham, K. J., Burton, D. A., & Cecchi, F. (2000) · Circulation · doi:10.1161/01.cir.102.8.858 · Cited by 677
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy
Monserrat, L., Elliott, P. M., Gimeno, J. R., Sharma, S., Penas-Lado, M., & McKenna, W. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00827-1 · Cited by 541
Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy
Elliot, P. M., Gimeno, J. R., Mahon, N., Poloniecki, J. D., & McKenna, W. J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04005-8 · Cited by 517
Gender-Related Differences in the Clinical Presentation and Outcome of Hypertrophic Cardiomyopathy
Olivotto, I., Maron, M. S., Adabağ, S., Casey, S. A., Vargiu, D., Link, M. S., Udelson, J. E., Cecchi, F., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.043 · Cited by 436
Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy
Elliot, P. M., Gimeno, J. R., Tome, M., Shah, J., Ward, D., Thaman, R., Mogensen, J., & McKenna, W. J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl041 · Cited by 428
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy
Driest, S. L. V., Vasile, V. C., Ommen, S. R., Will, M. L., Tajik, A. J., Gersh, B. J., & Ackerman, M. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.045 · Cited by 423
Hypertrophic cardiomyopathy in tuscany: Clinical course and outcome in an unselected regional population
Cecchi, F., Olivotto, I., Montereggi, A., Santoro, G., Dolara, A., & Maron, B. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00353-3 · Cited by 296
Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy
Elliot, P. M., Gimeno, J. R., Thaman, R., Shah, J., Ward, D., Dickie, S., Tome, M., & McKenna, W. J. (2005) · Heart · doi:10.1136/hrt.2005.068577 · Cited by 296
Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.
Anan, R., Greve, G., Thierfelder, L., Watkins, H. C., McKenna, W. J., Solomon, S. D., Vecchio, C., Shono, H., Nakao, S., & Tanaka, H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116957 · Cited by 285
Clinical Features and Prognostic Implications of Familial Hypertrophic Cardiomyopathy Related to the Cardiac Myosin-Binding Protein C Gene
Charron, P., Dubourg, O., Desnos, M., Bennaceur, M., Carrier, L., Camproux, A., Isnard, R., Hagège, A. A., Jm, L., Bonne, G., et al. (1998) · Circulation · doi:10.1161/01.cir.97.22.2230 · Cited by 279
Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy
Adabag, A. S., Casey, S. A., Kuskowski, M. A., Zenovich, A. G., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.043 · Cited by 273
Natural History of Hypertrophic Cardiomyopathy
Cannan, C. R., Reeder, G. S., Bailey, K. R., Melton, L. J., & Gersh, B. J. (1995) · Circulation · doi:10.1161/01.cir.92.9.2488 · Cited by 265
The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms
Autore, C., Bernabò, P., Barillà, C. S., Bruzzi, P., & Spirito, P. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.067 · Cited by 263
Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings.
Fananapazir, L., Chang, A. C., Epstein, S. E., & McAreavey, D. (1992) · Circulation · doi:10.1161/01.cir.86.3.730 · Cited by 259
Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
Elliot, P. M., Sharma, S., Varnava, A. M., Poloniecki, J. D., Rowland, E., & McKenna, W. J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00056-x · Cited by 257
Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy
Olivotto, I., Maron, B. J., Montereggi, A., Mazzuoli, F., Dolara, A., & Cecchi, F. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00094-7 · Cited by 254
Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.
Epstein, N. D., Cohn, G., Cyran, F., & Fananapazir, L. (1992) · Circulation · doi:10.1161/01.cir.86.2.345 · Cited by 230
Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations.
Fananapazir, L., & Epstein, N. D. (1994) · Circulation · doi:10.1161/01.cir.89.1.22 · Cited by 226
Dilated-Hypokinetic Evolution of Hypertrophic Cardiomyopathy
Biagini, E., Coccolo, F., Ferlito, M., Perugini, E., Rocchi, G., Reggiani, M. L. B., Lofiego, C., Boriani, G., Prandstraller, D., Picchio, F. M., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.062 · Cited by 224
Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration
Kofflard, M. J. M., ten Cate, F. J., van der Lee, C., & van Domburg, R. T. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)03004-8 · Cited by 218
Predictors of sudden cardiac death in hypertrophic cardiomyopathy
Maki, S., Ikeda, H., Muro, A., Yoshida, N., Shibata, A., Koga, Y., & Imaizumi, T. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00455-x · Cited by 216
Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia.
Spirito, P., Rapezzi, C., Autore, C., Bruzzi, P., Bellone, P., Ortolani, P., Fragola, P. V., Chiarella, F., Zoni-Berisso, M., & Branzi, A. (1994) · Circulation · doi:10.1161/01.cir.90.6.2743 · Cited by 204
Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy
McLeod, C. J., Ommen, S. R., Ackerman, M. J., Weivoda, P. L., Shen, W.-K., Dearani, J. A., Schaff, H. V., Tajik, A. J., & Gersh, B. J. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm117 · Cited by 203
Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease
Sorajja, P., Ommen, S. R., Nishimura, R. A., Gersh, B. J., Berger, P. B., & Tajik, A. J. (2003) · Circulation · doi:10.1161/01.cir.0000097110.55312.bf · Cited by 198
Prevalence and Severity of “Benign” Mutations in the β-Myosin Heavy Chain, Cardiac Troponin T, and α-Tropomyosin Genes in Hypertrophic Cardiomyopathy
Driest, S. L. V., Ackerman, M. J., Ommen, S. R., Shakur, R., Will, M. L., Nishimura, R. A., Tajik, A. J., & Gersh, B. J. (2002) · Circulation · doi:10.1161/01.cir.0000042675.59901.14 · Cited by 180
Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy
Olivotto, I., Gistri, R., Petrone, P., Pedemonte, E., Vargiu, D., & Cecchi, F. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02713-4 · Cited by 161
Homozygous Mutation in Cardiac Troponin T
Ho, C. Y., Lever, H. M., DeSanctis, R. W., Farver, C. F., Seidman, J. G., & Seidman, C. E. (2000) · Circulation · doi:10.1161/01.cir.102.16.1950 · Cited by 150
Sudden cardiac death in hypertrophic cardiomyopathy
Marian, A. J., Mares, A., Kelly, D. P., Yu, Q., Abchee, A., Hill, R., & Roberts, R. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060920 · Cited by 139
Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy
Erdmann, J., Raible, J., Abadi, J. M., Hammann, J., Wollnik, B., Frantz, E., Fleck, E., Regitz‐Zagrosek, V., Hummel, M. W., & Hetzer, R. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01387-0 · Cited by 139
Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest
Cecchi, F., Maron, B. J., & Epstein, S. E. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90302-1 · Cited by 136
Clinical Features of Hypertrophic Cardiomyopathy Caused by Mutation of a “Hot Spot” in the Alpha-Tropomyosin Gene
Coviello, D. A., Maron, B. J., Spirito, P., Watkins, H. C., Vosberg, H.-P., Thierfelder, L., Schöen, F. J., Seidman, J. G., & Seidman, C. E. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00538-4 · Cited by 127
Prognosis in hypertrophic cardiomyopathy observed in a large clinic population
Kofflard, M. J. M., Waldstein, D. J., Vos, J., & ten Cate, F. J. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)91111-t · Cited by 127
Molecular Genetic Basis of Hypertrophic Cardiomyopathy:
Marian, A. J., & Roberts, R. (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb00871.x · Cited by 115
New Concepts in Hypertrophic Cardiomyopathies, Part II
Roberts, R., & Sigwart, U. (2001) · Circulation · doi:10.1161/hc4301.097430 · Cited by 113
Natural history of hypertrophic cardiomyopathy in the elderly
Fay, W. P., Taliercio, C. P., Ilstrup, D. M., Tajik, A. J., & Gersh, B. J. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80328-6 · Cited by 106
Genotype–phenotype correlations in familial hypertrophic cardiomyopathy A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes
Charron, P. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0575 · Cited by 105
Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene
Deprez, R. H. L., Muurling-Vlietman, J. J., Hruda, J., Baars, M. J. H., Wijnaendts, L. C. D., Stolte‐Dijkstra, I., Alders, M. M., & van Hagen, J. M. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.040329 · Cited by 101
Double heterozygosity for mutations in the β-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy
Richard, P., Isnard, R., Carrier, L., Dubourg, O., Donatien, Y., Mathieu, B., Bonne, G., Gary, F., Charron, P., Hagège, A. A., et al. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.7.542 · Cited by 92
Implantable Cardioverter-Defibrillator Therapy for Primary Prevention of Sudden Death After Alcohol Septal Ablation of Hypertrophic Cardiomyopathy
Cuoco, F. A., Spencer, W. H., Fernandes, V. L. C., Nielsen, C. D., Nagueh, S. F., Sturdivant, J. L., Leman, R. B., Wharton, J. M., & Gold, M. R. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.061 · Cited by 90
Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy
Takagi, E., Yamakado, T., & Nakano, T. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00555-5 · Cited by 83
Incidence of Ischemic Strokes in Hypertrophic Cardiomyopathy is Markedly Increased if Complicated by Atrial Fibrillation
Higashikawa, M., Nakamura, Y., Yoshida, M., & Kinoshita, M. (1997) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.61.673 · Cited by 80
Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.
DEpstein, N., MCohn, G., FCyran, & LFananapazir (1992) · Circulation · Cited by 75
Rate-modulated cardiac pacing based on transthoracic impedance measurements of minute ventilation: Correlation with exercise gas exchange
Kay, G. N., Bubien, R. S., Epstein, A. E., & Plumb, V. J. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90429-4 · Cited by 71
Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy†
D’Andrea, A., Caso, P., Severino, S., Cuomo, S., Capozzi, G., Calabrò, P., Cice, G., Ascione, L., Scherillo, M., & Calabrò, R. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi688 · Cited by 64
Homozygotes for a R869G Mutation in the β -myosin Heavy Chain Gene have a Severe Form of Familial Hypertrophic Cardiomyopathy
Richard, P., Charron, P., Leclercq, C., Ledeuil, C., Carrier, L., Dubourg, O., Desnos, M., Bouhour, J.-B., Schwartz, K., Daubert, J., et al. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1193 · Cited by 63
Genotype: phenotype correlations in hypertrophic cardiomyopathy.
Watkins, H. C. (1998) · PubMed · Cited by 62
Hypertrophic cardiomyopathy: Is a left ventricular outflow tract gradient a major prognostic determinant?
Romeo, F., Pelliccia, F., CRISTOFANII, R., Martuscelli, E., & Reale, A. (1990) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059689 · Cited by 53
A new missense mutation, Arg719Gln, in the β-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy
Consevage, M. W., Salada, G. C., Baylen, B. G., Ladda, R. L., & Rogan, P. K. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.6.1025 · Cited by 52
Hypertrophic cardiomyopathy in the elderly: significance of atrial fibrillation.
Doi, Y., & Kitaoka, H. (2001) · PubMed · Cited by 43
Relation of QRS Duration to Mortality in a Community-Based Cohort With Hypertrophic Cardiomyopathy
Bongioanni, S., Bianchi, F., Migliardi, A., Gnavi, R., Pron, P. G., Casetta, M., & Conte, M. R. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.049 · Cited by 41
Early expression of a malignant phenotype of familial hypertrophic cardiomyopathy associated with a Gly716Arg myosin heavy chain mutation in a Korean family
Hwang, T. H., Lee, W., Kimura, A., Satoh, M., Nakamura, T., Kim, M.-K., Choi, S.-K., & Park, J.-E. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00695-x · Cited by 40
Echocardiographic risk factors predisposing to sudden cardiac death in hypertrophic cardiomyopathy: Figure 1
Dimitrow, P. P., & Dubiel, J. S. (2004) · Heart · doi:10.1136/hrt.2003.030353 · Cited by 30
The val606met mutation in the cardiac beta-myosin heavy chain gene in patients with familial hypertrophic cardiomyopathy is associated with a high risk of sudden death at young age
Havndrup, O., Bundgaard, H., Andersen, P. S., Larsen, L. A., Vuust, J., Kjeldsen, K. P., & Christiansen, M. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01532-6 · Cited by 29
Prognostic value of intra-left ventricular electromechanical asynchrony in patients with mild hypertrophic cardiomyopathy compared with power athletes
D’Andrea, A., Caso, P., Cuomo, S., Salerno, G., Scarafile, R., Mita, C., Corato, G. D., Sarubbi, B., Scherillo, M., & Calabrò, R. (2006) · British Journal of Sports Medicine · doi:10.1136/bjsm.2005.022194 · Cited by 28
Long-term follow-up of R403WMYH7 and R92WTNNT2 HCM families: mutations determine left ventricular dimensions but not wall thickness during disease progression.
Revera, M., van der Merwe, L., Heradien, M. J., Goosen, A., Corfield, V. A., Brink, P. A., & Moolman‐Smook, J. C. (2007) · PubMed Central · Cited by 21
Electrocardiographic findings in patients with hypertrophic cardiomyopathy
Pelliccia, F., Cianfrocca, C., Cristofani, R., Romeo, F., & Reale, A. (1990) · Journal of Electrocardiology · doi:10.1016/0022-0736(90)90159-y · Cited by 11

Sorted by citations

2018 ESC Guidelines for the diagnosis and management of syncope
Brignole, M., Moya, A., de Lange, F. J., Deharo, J.-C., Elliott, P. M., Fanciulli, A., Fedorowski, A., Furlan, R., Kenny, R. A., Martín, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy037 · Cited by 1,951
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Marian, A. J., & Braunwald, E. (2017) · Circulation Research · doi:10.1161/circresaha.117.311059 · Cited by 1,403
Hypertrophic Cardiomyopathy
Maron, B. J., Ommen, S. R., Semsarian, C., Spirito, P., Olivotto, I., & Maron, M. S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.003 · Cited by 652
2018 ESC Guidelines for the diagnosis and management of syncope
Brignole, M., Moya‐Mitjans, À., de Lange, F. J., Deharo, J., Elliot, P. M., Fanciulli, A., Fedorowski, A., Furlan, R., Kenny, R. A., Martiın, A., et al. (2018) · Kardiologia Polska · doi:10.5603/kp.2018.0161 · Cited by 475
Patterns of Disease Progression in Hypertrophic Cardiomyopathy
Olivotto, I., Cecchi, F., Poggesi, C., & Yacoub, M. H. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.967026 · Cited by 352

See all 176

Authors: Christiaans, I., van Engelen, K., van Langen, I. M., Birnie, E., Bonsel, G. J., Elliott, P. M., & Wilde, A. A. M.
Affiliations: Amsterdam UMC Location University of Amsterdam (NL)
Erasmus MC (NL)
Corresponding author: Wilde, Arthur A.M.
ORCID: Christiaans, Imke
Birnie, Erwin
Bonsel, Gouke J.
Wilde, Arthur A.M.
Venue: EP Europace
Publisher: Oxford University Press (OUP)
Published: 2010-01-29
Volume: 12
Issue: 3
Pages: 313-321
ISSN: 1099-5129 (ISSN-L)
1532-2092
DOI: 10.1093/europace/eup431
OpenAlex: W2120813609
Cited by: 176
References: 69
Citations by year: 2026: 3 · 2025: 10 · 2024: 3 · 2023: 5 · 2022: 8 · 2021: 5 · 2020: 7 · 2019: 18 · 2018: 20 · 2017: 13 · 2016: 13 · 2015: 13 · 2014: 8 · 2013: 16 · 2012: 15
FWCI: 2.61
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: other-oa
Locations: EP Europace (publishedVersion)
PubMed (publishedVersion)
Pure Amsterdam UMC (publishedVersion)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: hypertrophic cardiomyopathy, sudden cardiac death, risk stratification, left ventricular outflow tract obstruction, left ventricular hypertrophy, ventricular tachycardia, syncope, family history of sudden death, blood pressure response, cardiac arrest
MeSH terms: Cardiomyopathy, Hypertrophic, Humans, Prognosis, Risk Factors, Death, Sudden, Cardiac, Practice Guidelines as Topic, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks